Similar articles

• [Systemic therapy of metastatic malignant melanoma].

  Stahel RA, Martz G. Stahel RA, et al. Schweiz Rundsch Med Prax. 1988 Apr 26;77(17):459-62. Schweiz Rundsch Med Prax. 1988. PMID: 3259710 German. No abstract available.
• What can we learn from phase II adjuvant trials in melanoma?

  Keilholz U, Suciu S, Eggermont AM. Keilholz U, et al. Br J Cancer. 2000 Jul;83(1):6-7. doi: 10.1054/bjoc.2000.1277. Br J Cancer. 2000. PMID: 10883660 Free PMC article. No abstract available.
• [Chemotherapy of malignant melanoma].

  Karakousis CP. Karakousis CP. Chirurg. 1986 Oct;57(10):606-11. Chirurg. 1986. PMID: 3792110 German. No abstract available.
• [Treatment of metastasized malignant melanoma].

  Kamanabrou D. Kamanabrou D. Praxis (Bern 1994). 2001 Mar 8;90(10):391-6. Praxis (Bern 1994). 2001. PMID: 11305184 Review. German.
• Role of recombinant interleukin-2 in combination with interferon-alfa and chemotherapy in the treatment of advanced melanoma.

  Legha SS, Buzaid AC. Legha SS, et al. Semin Oncol. 1993 Dec;20(6 Suppl 9):27-32. Semin Oncol. 1993. PMID: 8054006 Review. No abstract available.